EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Metabolic programming and immune suppression in the tumor microenvironment

Emily N Arner, Jeffrey C Rathmell

Cancer Cell · 2023-03 · 41 (3) · 421-433

DOI: 10.1016/j.ccell.2023.01.009 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Cell, 2023-03. Verfasst von Emily N Arner und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Vanderbilt University Medical Center (VUMC), Nashville, TN, USA. Hauptthemen laut MEDLINE: Tumor Microenvironment, Neoplasms. Die Arbeit wurde bisher 701-mal zitiert (Crossref) und nennt 141 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIDDK NIH HHS, Pfizer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Increased glucose metabolism and uptake are characteristic of many tumors and used clinically to diagnose and monitor cancer progression. In addition to cancer cells, the tumor microenvironment (TME) encompasses a wide range of stromal, innate, and adaptive immune cells. Cooperation and competition between these cell populations supports tumor proliferation, progression, metastasis, and immune evasion. Cellular heterogeneity leads to metabolic heterogeneity because metabolic programs within the tumor are dependent not only on the TME cellular composition but also on cell states, location, and nutrient availability. In addition to driving metabolic plasticity of cancer cells, altered nutrients and signals in the TME can lead to metabolic immune suppression of effector cells and promote regulatory immune cells. Here we discuss how metabolic programming of cells within the TME promotes tumor proliferation, progression, and metastasis. We also discuss how targeting metabolic heterogeneity may offer therapeutic opportunities to overcome immune suppression and augment immunotherapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentNeoplasmsHumansImmunotherapyLymphocytes

Stichwörter der Autor:innen

immunemetabolismmetastasisplasticitytumor microenvironment

Autor:innen und Institutionen

  • Department of Medicine, Vanderbilt University Medical Center (VUMC), Nashville, TN, USA.
  • Vanderbilt Center for Immunobiology, Vanderbilt University Medical Center (VUMC), Nashville, TN, USA; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center (VUMC), Nashville, TN, USA; Department of Patho…

Förderung

  • NCI NIH HHS
  • NIDDK NIH HHS
  • Pfizer
  • National Cancer Institute
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Arner, E. N., & Rathmell, J. C. (2023). Metabolic programming and immune suppression in the tumor microenvironment. Cancer Cell, 41(3), 421-433. https://doi.org/10.1016/j.ccell.2023.01.009

Vancouver

Arner EN, Rathmell JC. Metabolic programming and immune suppression in the tumor microenvironment. Cancer Cell. 2023;41(3):421-433. doi:10.1016/j.ccell.2023.01.009

BibTeX
@article{Arner2023,
  author = {Arner, Emily N and Rathmell, Jeffrey C},
  title = {Metabolic programming and immune suppression in the tumor microenvironment},
  journal = {Cancer Cell},
  year = {2023},
  volume = {41},
  number = {3},
  pages = {421--433},
  doi = {10.1016/j.ccell.2023.01.009}
}
Kostenlos starten →